Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction to: Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association.

Circulation·2025

Same author

Therapeutic Efficacy of a Novel Pharmacologic GRK2 Inhibitor in Multiple Animal Models of Heart Failure.

JACC. Basic to translational science·2025

Same author

Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association.

Circulation·2025

Same author

Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells.

Cancer cell·2024

Same author

Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?

Circulation·2024

Same author

Thyroid Hormone Suppresses Medulloblastoma Progression Through Promoting Terminal Differentiation of Tumor Cells.

bioRxiv : the preprint server for biology·2024

Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026

Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026

Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025

Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025

Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025

Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Stem cell therapy for heart failure.

David Angert¹, Steven R Houser

¹Department of Physiology, Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA, USA.

Current Treatment Options in Cardiovascular Medicine

|July 25, 2009

Summary

This summary is machine-generated.

Cell therapy shows promise for heart failure (HF) treatment. Enriched stem cell populations offer the best chance for cardiac repair and improving function in patients with chronic heart failure.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Related Experiment Videos

Last Updated: Jun 21, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Area of Science:

Regenerative Medicine
Cardiovascular Research
Cell-Based Therapies

Background:

Heart failure (HF) is a chronic condition with limited treatment options, often necessitating cardiac transplantation.
Current therapies manage symptoms but do not significantly reduce mortality.
Novel approaches are crucial to improve outcomes and reduce the need for transplantation.

Purpose of the Study:

To review current cell therapy clinical trials for patients with chronic heart failure (HF).
To evaluate the safety and efficacy of different cell types and delivery methods.
To identify promising cell-based strategies for cardiac repair and regeneration.

Main Methods:

Review of phase 1 and phase 2 clinical trials involving cell therapy for chronic HF.
Analysis of studies using skeletal myoblasts, bone marrow-derived mononuclear cells, and stem cell subpopulations.
Evaluation of delivery techniques including intracoronary infusion and direct myocardial injection.

Main Results:

Intracoronary and direct injection of stem cells demonstrated safety in clinical trials.
Skeletal myoblast implantation improved cardiac function but raised concerns regarding tissue integration.
Bone marrow-derived cells and stem cell subpopulations showed potential for cardiac repair, with mixed but encouraging results.

Conclusions:

Cell therapy, particularly using enriched subpopulations of cardiac and bone marrow stem cells, is safe and shows significant potential for cardiac repair in chronic HF.
While challenges remain, these cell-based approaches offer the most promising avenue for legitimate medical therapy in heart failure.
Further research and clinical trials are needed to optimize cell therapy strategies for heart failure patients.